President Donald J. Trump issued an executive order on December 18, 2025, instructing the attorney general to accelerate the federal rulemaking process for reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act. The directive aims to enhance medical research on cannabis and cannabidiol products, addressing long-standing barriers to scientific study and […]
